Efficacy of second-line chemotherapy after a first-line triplet in patients with metastatic colorectal cancer

BACKGROUND: Exposing patients with metastatic colorectal cancer (mcrc) to all three active chemotherapeutic agents (oxaliplatin, irinotecan, fluorouracil) has improved survival. The benefit of second-line chemotherapy after a first-line triplet is not clearly defined. We evaluated the efficacy of se...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Curr Oncol
Main Authors: Bazarbashi, S., Hakoun, A.M., Gad, A.M., Elshenawy, M.A., Aljubran, A., Alzahrani, A.M., Eldali, A.
Format: Artigo
Sprog:Inglês
Udgivet: Multimed Inc. 2019
Fag:
Original Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6380651/
https://ncbi.nlm.nih.gov/pubmed/30853806
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.26.4217
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker